Cargando…
Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV
BACKGROUND: High dosage of intravenous immunoglobulin (IVIG) has been observed as a possible activator of HIV gene expression in latently infected resting CD4(+ )T-cells, leading to a substantial decrease in both the reservoir and the residual plasma viremia when added to effective ART. IVIG treatme...
Autores principales: | Mellberg, Tomas, Gonzalez, Veronica D, Lindkvist, Annica, Edén, Arvid, Sönnerborg, Anders, Sandberg, Johan K, Svennerholm, Bo, Gisslén, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136401/ https://www.ncbi.nlm.nih.gov/pubmed/21708049 http://dx.doi.org/10.1186/1742-6405-8-21 |
Ejemplares similares
-
Reduction of the HIV-1 reservoir in resting CD4(+ )T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study
por: Lindkvist, Annica, et al.
Publicado: (2009) -
Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020) -
Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
por: Edén, Arvid, et al.
Publicado: (2023) -
All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
por: Elvstam, Olof, et al.
Publicado: (2020) -
1564 Duration of Viral Suppression and objectively measured Antiretroviral Adherence as predictors of rebound Viremia in South Western Uganda
por: Musinguzi, Nicholas
Publicado: (2014)